28
Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital

Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital

Embed Size (px)

Citation preview

Testicular Cancers

Ashray GunjurIntern, Royal Melbourne Hospital

Did you know?

• That the words testify, testimonial and testament are derived from...

Anatomy

http://www.aboutcancer.com/testicle_anatomy1.jpg

Differentials

HISTORY?* Pain??* Time course of symptoms?

PHYSICAL EXAM?* pain?* reducibility?* Lie of teste?

Differentials

Toronto Notes 2010

Differentials

• 2) Epidydymal cyst/Spermatocele

Differential

• 3) Varicocele

Typical case

• Young man with painless growth of unilateral teste

• On examniation, firm nontender, non-transilluminating mass in one of the testes

Epidemiology

• Relatively rare- 1-2% of men, but..• Most common malignancy in age 20-40• Three peak model: infancy, 30-34 years, >60

years

Risk factors

• Cryptorchidism- 4-8x risk of germ cell tumour– Risk still increased after orchiopexy in pt <6yrs old-

2.23x*– Risk still increased in contralateral testis- 5-20% of

malignancy in normal descended testis!• Prior testicular cancer- 500x– Approx 1-2% of testicular cancer patients will

develop a second primary contralaterally...

*Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med. May 3 2007;356(18):1835-41

Risk factors

• Genetics– E.g. Klinefelter syndrom (47XXY)- germ cell

tumours• Diethylstilbestrol (DES) exposure in utero– E.g. ‘Agent Orange’, Industrial occupation

Diagnosis

• Best first testhypoechoic lesion

Diagnosis

• Gold standard?

- inguinal orchidectomy!!

Histologic types

Germ cell tumors (>95%):Seminoma (40%) versus Non seminomatous germ

cell tumors (NSGCT) (40%) vs. mixed (15%)

Non-germ cell tumors (rare, <5%)Leydig cell tumors (precocious puberty)Sertoli cell tumors Mixed sex chord-stromal tumors

Germ cell tumours

• Seminoma (40%)– Generally favourable prognosis, tend to be in older men– Rarely make B-HCG (15%), no aFP (0%)

• Non-seminoma (40%)– Choriocarcinoma

(elevated b-HCG (50%), haematogenous spread)– Embryonal cell– Teratoma (mature and immature)– Yolk sac

(elevated AFP)

Tumour markers

• AFP levels are elevated 50%-70% NSGCT• hCG levels are elevated in 40%-60% NSGCT. • AFP has a half-life of 5-7 days• hCG has a half-life of 36 hours. • Important to follow response after

orchiectomy• LDH is non-specific measure of tumor burden

Risk stratification• Good-risk nonseminoma• Testicular or retroperitoneal primary tumor, and• No nonpulmonary visceral metastases, and• Good markers; all of:Alpha-fetoprotein (AFP) < 1,000 ng/mL, and• Human chorionic gonadotropin (hCG) < 5,000 IU/mL (1,000 ng/mL), and• Lactate dehydrogenase (LDH) < 1.5 times the upper limit of normal

• Intermediate-risk nonseminoma• Testicular or retroperitoneal primary tumor, and• No nonpulmonary visceral metastases, and• Intermediate markers; any of:AFP 1,000 to 10,000 ng/mL, or• hCG 5,000 IU/L to 50,000 IU/L, or• LDH 1.5 to 10 times the upper limit of normal

• Poor-risk nonseminoma• Mediastinal primary, or• Nonpulmonary visceral metastases, or• Poor markers; any of:AFP > 10,000 ng/mL, or• hCG > 50,000 IU/mL (10,000 ng/mL), or• LDH > 10 times the upper limit of normal

Risk stratification

• Good-risk seminoma• Any primary site, and• No nonpulmonary visceral metastases, and• Normal AFP, any hCG, any LDH• Intermediate-risk seminoma• Any primary site, and• Nonpulmonary visceral metastases, and• Normal AFP, any hCG, any LDH• Poor-risk seminoma• No such thing!!

TreatmentPost Orchidectomy…

SeminomaStage IA and B: radiation therapy vs surveillance (? Chemo)NSGCTStage IAretroperitoneal lymph node dissection vs surveillanceStage IBretroperitoneal lymph node dissection vs surveillance vs

chemotherapy

Higher stages-chemo, f/b surgery as needed

Retroperitoneal Lymph Node Dissection

Why?

• Non-seminomas are more aggressive than seminomas

• RPLND is used to guide chemotherapy– No of +ive nodes correlates to cycles of chemo

Surveillance

NCCN guidelines• CT q 2-3 months for first year or two• Then q4, q6• Labs, CXR q month for year one, then q 2

months, etc

• Issues are compliance, anxiety

Question 1

The most common presenting complaint for a testicular cancer is:

a) a painless swelling of a single testeb) a red, painful scrotumc) haematuriad) back pain

Question 2

• All of the following are a risk factor for testicular cancers, save

a) Cryptorchidismb) Maternal DES exposurec) Caucasian raced) Repeated testicular trauma

Question 3

The following statements are false, savea) Testicular cancer is the most common cancer of

infancyb) There are more men aged 15-25 diagnosed with

testicular cancer than >50c) Unilateral surgical orchidectomy precludes the

chance of testicular cancer recurringd) Unilateral surgical orchidectomy is the gold

standard diagnostic procedure for testicular cancer

Question 4

Routine workup and staging of diagnosed testicular cancer should include:

a) a-FPb) B-HcGc) CT A/P + Cd) PET scan

Question 5

The following are incorrect about Seminomas, save

a) Ultrasound features often involve heterogenous cystic components

b) aFP is often raised and used for prognostication

c) Para-aortic radiotherapy is often indicatedd) Patients with metastatic disease have a poor

prognosiss